EBD Group today announced that registrations for BIO-Europe Spring
2008, April 7-9, 2008 in Palacio Municipal de Congresos, Madrid,
Spain, are up 30 percent from last year´s highly successful inaugural
event in Milan, Italy.
In addition, BIO-Europe Spring has received the unanimous backing
of the Spanish Bio-Pharma Industry, including Almirall, Esteve, Grupo
Uriach, Cellerix and the backing of local hosts of Madrid Biocluster,
PromoMadrid, IMADE, Camara de Madrid, Genoma Espana, Interes,
Fundacion para el Conocimiento madri+d and CEIM.
"The companies and research activities based around Madrid form
the heart of Spain´s emerging biotechnology industry. Today, Madrid
leads Spain with 27 percent of total biotech companies and,
significantly, accounts for 45.2 percent of sales and 45.5 per cent of
employment by biotech companies. PromoMadrid is very excited to be the
host of the BIO-Europe Spring 2008 event, which will help illuminate
the rapid progress of our industry, the undisputed quality of our
science and the great potential for partnering with Spanish biotechs,"
said Jesus Sainz, Chairman of PromoMadrid.
Overall, the number of biotech firms in Spain has doubled in the
last six years to 150, half of which are focused on product discovery
and development. There are over 500 enterprises in Spain that are
engaged in the biotech arena, producing a turnover in excess of EUR
20,000 Million.
"The prosperity of the Spanish biotech industry requires forming
collaborations with firms from around the world and educating the
biotech industry on the many benefits of forming alliances with
world-class companies and research institutions in Spain," said Dr.
Josep Lamarca, Senior Director of Corporate Development Licensing
Projects, Almirall. "As one of the largest stand-alone partnering
conferences, BIO-Europe Spring in Madrid will enable the biotech
industry elite to fully appreciate the deal-making potential in Spain,
as well as engage with potential collaborators from across the
biotechnology spectrum."
BIO-Europe Spring utilizes partneringONE(TM), the industry´s most
trusted and intuitive web-based conference partnering system that is
purpose-built to create and facilitate connections among companies
across entire global industry value-chains.
"We look forward to a highly productive and exciting conference in
Madrid," said Carola Schropp, EBD Group´s managing director. "The
success of BIO-Europe Spring among key pharma-biotech players is the
powerful mix of "virtual" online collaboration with a stimulating
physical event. Partnering in all its complexity, whether based on
product licensing or a technology transfer, whether for a merger or
acquisition, the process must start with a contact and targeting the
right partners at the right time."
Notes to Editors:
Entry to BIO-Europe Spring 2008 is free to the media, including
full access to the partnering system, sessions, press conferences,
workshops, and pre-arranged partnering meetings. Visit the BIO-Europe
Spring conference website at http://www.ebdgroup.com/bes/press_reg.htm
for detailed information on this year´s conference and online
registration. When you register online, please indicate in the comment
field that you are requesting a complimentary press registration.
Please fax a copy of your press pass to complete your complimentary
media registration to fax number +49 (89) 23 88 756 55.
About BIO-Europe Spring 2008
The BIO-Europe Spring(TM) event brings together international
decision-makers from all sectors of the biotechnology industry, and
features the successful combination of one-to-one meetings, company
presentations, panel discussions and a lively exhibition.
Positioned as the springtime counterpart to EBD Group´s flagship
conference, BIO-Europe, the BIO-Europe Spring event continues the
tradition of providing life science companies with high calibre
partnering opportunities. The event enables biotechnology companies to
identify, meet and network with companies across the biotechnology
value-chain from large biotech and pharma companies to financiers and
innovative start-ups.
About EBD Group
EBD Group is the leading partnering firm for the global
biotechnology industry. Since 1993, firms in the life sciences have
leveraged EBD Group´s partnering conferences, technology and services
to identify business opportunities and develop strategic relationships
that drive their business. EBD Group´s conferences (run in
collaboration with leading industry partners and international trade
associations) include BIO-Europe, the world´s largest stand-alone life
science partnering conference (co-organized with BIO); BIO-Europe
Spring(R); and BioEquity Europe (co-organized with BioCentury
Publications and BIO). EBD´s novel, web-based, partnering service
partneringONE(TM) is also used at numerous third-party events around
the world. Outside of the conference format, EBD Group´s consultants
can provide hands-on assistance for firms seeking to in- or
out-license products and technologies. EBD Group has offices in San
Diego and London.
For more information visit www.ebdgroup.com
